Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries

• Main Authors: Marco Schäferhoff, PhD (Author), Armand Zimmerman, MS (Author), Mohamed M Diab, MD (Author), Wenhui Mao, PhD (Author), Vipul Chowdhary, MD (Author), Davinder Gill, PhD (Author), Robert Karanja, PhD (Author), Mziwandile Madikizela, PhD (Author), Osondu Ogbuoji, ScD (Author), Gavin Yamey, ProfMD (Author)
• Format: Book
• Published: Elsevier, 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Investing in late-stage clinical trials, trial sites, and production capacity for new health products could improve access to vaccines, therapeutics, and infectious disease diagnostics in middle-income countries. This study assesses the case for such investment in three of these...